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Neopterin measurements are especially useful as an early
marker in (e.g.) allograft rejections and in patients infected
with human immunodeficiency virus type 1 (H1V-1). An
increased concentration of total neopterins (neoptenn +
dihydroneopterin) is also a significant marker in patients with
H1V-1 infection, in this study we compared concentrations of
neopterin and total neopterins in urine samples from 77
homosexual men with and 73 without established H1V-1
infection. H1V-1-seropositive homosexual men had higher
concentrations of neopterin and total neopterins (and 7,8-
dihydroneopterin) in their urine than did those who were
HIV-1 -seronegative, and there was a close correlation be-
tween neopterin and total neopterins. Both neopterin vana-
bles correlated inversely with CD4 T-cell counts and CD4/
CD8 T-cellratiosbut not withCD8 T-celIcounts inthe
H1V-1-seropositive men. Our data indicate that measure-
ments of neopterin and total neopterins are of almost equal
potential for clinical diagnosis. However, when measuring
total neopterins, which includes oxidation of 7,8-dihydro-
neoptenn to neopterin,more strict requirements of sample
collection and handling are necessary to avoid degradation
of the 7,8-dihydro derivative.
Additional Keyphrases: dihydroneopterin urine human
immunodeficiency virus T-cell subpopulation acquired im-
mune deficiency syndrome
7,8-Dihydroneopterin triphosphate is the first intermedi-
ate on the de novo biosynthetic pathway from guanosine
triphosphate to 5,6,7,8-tetrahydrobiopterin (1), the cofactor
of the monooxygenases phenylalanine-4-monooxygenase
(EC 1.14.16.1), tyrosune-3-monooxygenase (BC 1.14.16.2),
and tryptophan-5-monooxygenase (EC 1.14.16.4) (2, 3).
Inborn deficiency of tetrahydrobiopterin is known as an
atypical form of phenylketonuria.
Recently it has been shown that concentrations of 6-
D-erythro-trihydroxypropylpterin (neopterun), a metabolite
of dthydroneopterin triphosphate, are an indicator of cellu-
lar immune response in humans. Neopterin measurements
provide important information in several disease states (4,
5) and are especially useful as an early marker in allograft
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rejections and infectious complications in graft recipients.
Neopterin concentrations parallel disease activity and re-
veal predictive information about autoimmune disease
such as rheumatoid arthritis and systemic lupus erythema-
tosus, about cancer, and about infectious diseases. Neop-
term testing also may be valuable in evaluating patients
infected with human immunodeficiency virus type I (HIV-
1) (4-8).
The utility of the neopterin test in clinical settings has
been investigated mostly by direct measurement of neop-
term in body fluids (5-9). Neopterin is formed from 7,8-
dihydroneopterin by as-yet-uncharacterized oxidation reac-
tions; dihydroneopterin is produced by dephosphorylation
of dihydroneopterin triphosphate in body fluids. An in-
creased concentration of total neopterins (i.e., neopterin +
dihydroneopterin) has also been shown to be a significant
marker in patients with H1V-1 infection (8, 10).
In this study we quantified concentrations of neopterin
and total neopteruns in urine samples from homosexual
men with and without established HIV-1 infection. The
significance of neopterin data was compared with analyses
of T-cell subpopulations.
Patients and Methods
Patients: A cohort of 150 homosexual men was investi-
gated, including 69 who were anti-H1V-1 seropositive with-
out AIDS and eight who had AIDS at the time of specimen
collection (for a detailed description of the subjects, see refs.
8 and 11). HW-1 antibodies were determined by a commer-
cial ELISA (Electronucleonics Inc., Columbia, MD) with
Western blot confirmation (Biotech Inc., Rockville, MD).
Whole-blood samples for T-cell subset quantification and
urines were collected at the same visit. Urine samples were
frozen at -20 #{176}Cuntil measurement of neopterin, total
neopterins, and creatimne by the two different laboratories
(3,4).
Quantification of neopterin: Concentrations of neopterun
were quantified by direct measurement without oxidative
pretreatment of samples as described (7), briefly as follows.
We diluted 100 L of urine with 1 mL of S#{248}rensen’s
potassium phosphate buffer (15 mmol/L, pH 6.4) and in-
jected 10 L of this onto 125 x 4 mm C,8 reversed-phase
columns (LiChroCart; Merck, Darmstadt, F.R.G.) at 25#{176}C.
Compounds were eluted at a flow rate of 0.8 mL/min.
Neopterin was monitored by its native fluorescence (353
nm excitation, 438 nm emission). To account for physiolog-
ical variations in urine excretion, we related neopterin
concentrations to urinary creatinine concentrations, which
were quantified in the same chromatographic run by mea-
suring the absorbance at 235 nm.
Quantification of total neopterins: Concentrations of total
neoptermns were quantified as described previously (12).
Urine (10 jL) was added to 190 L of 0.2 mol/L H3P04
06000
4000-
II)
C
a)
0)0
‘ ‘-
. o.
0
00
- ,-
-- 0.
00
E
0 0
0
0
0 00
0
1000 1500 2000
neoptern
(jimol/mol creotinine)
without oxidative
pretreatment
2306 CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989
reagent, followed by 10 mg of manganese dioxide (Mn02).
After they were mixed and left standing for 10 miii at room
temperature, the samples were centrifuged and the super-
nates were filtered. For HPLC analysis, 10 1L was injected
onto C,8 reversed-phase columns (Partisil 10-1m particles,
ODS-2; Whatman, Clifton, NJ) and the effluent was moni-
tored by a fluorescence detector (Type 121; Gilson Medical
Electronics, Villiers-Le Bel, France). The eluent was meth-
anollwater (5/95 by vol) at a flow rate of 1.0 mL/mun. The
HPLC system consisted of a Model 6000 HPLC pump and
WISP automatic sample injector (both from Waters Asso-
ciates, Milford, MA), and a CR-lA recording integrator
(Shimadzu, Kyoto, Japan). Creatinine concentrations were
measured with a commercially supplied colorimetric assay
(cat. no. 555; Sigma Chemical Co., St. Louis, MO).
Concentrations of 7,8-dihydroneopterin: Manganese di-
oxide oxidizes 7,8-dihydroneopterin to neopterin. We there-
fore calculated the concentration of 7,8-dihydroneopterin
as the difference between total neopterins and neopterin
(all values adjusted for creatinine excretion). Results were
expressed as micromoles of 7,8-dihydroneopterin per mole
of creatinine.
Quantification of T-cell subpopulations: T-cell subsets
were measured in frozen/thawed lymphocytes with a fluo-
rescence-activated cell sorter and monoclonal antibodies
OKT4 and OKT8 (Ortho Diagnostics Co., Raritan, NJ) as
measures of CD4-T-helper and CD8-T-suppressor sub-
sets, respectively. The CD4 and CD8 T-cell counts were
defined as the total peripheral blood lymphocyte count
multiplied by the proportion of mononuclear cells stained
by OKT4 or OKT8.
Statistics: For comparison of grouped data we used the
Kruskal-Wallis test. For assessing correlations between
variables we applied the Spearman rank statistic.
Results
Concentrations of total neopterins in urine were about
fourfold that of neopterin in the HIV-1-seronegative and
-seropositive individuals (Table 1). The ratio of 7,8-dihydro-
neopterin (total neopterins minus neopterin) to neopterin is
therefore about 3:1. Only in a few samples were larger
ratios seen; e.g., in one H1V-1-seropositive man, total
neopterins were 448 mol per mole of creatinine, only
marginally higher than neopterin (427 .tmol per mole of
creatinine). In contrast, one HIV-1-seropositive man had
- 16-fold more total neopterins (6070 p.mol per mole of
creatinine) than neopterin (353 mol per mole of creati-
nine; Figure 1).
The HIV-l-seropositive men had higher concentrations
of neopterin and total neopterins (and 7,8-dihydroneop-
tern) in their urine than did the HIV-1-seronegative men.
AIDS patients had the highest concentrations (Table 1).
There was a close correlation between neopterin and
Fig. 1. Correlationbetween concentrations of neoptenn and total
neopterins in urine samples from the 150 HIV-1-seropositiveand
-seronegative subjects studied
Rs = 0.838 (P <0.0001) by Spearmari rank correlation
total neopterins (Figure 1). The correlation was also signif.
icant between neopterin and 7,8-dthydroneopterin concen-
trations (Es = 0.714, P <0.0001).
In the HN-1-seropositive individuals, all neopterin var-
iables correlated inversely to CD4 T-cell counts and
CD4/CD8 T-cell ratios but not to CD8 T-cell counts
(Table 2). No such correlation was found in the seronega-
tive subjects.
Discussion
In this study urinary neopterin concentrations correlated
significantly with the concentrations of total neopterins
(Figure 1), both in healthy anti-HIV-1-seronegative home-
sexuals and in homosexuals with established HIV-l infec-
tion. Concentrations of 7,8-dihydroneopterin averaged
three-fold the neopterin concentrations. However, the ratio
of total neopterins to 7,8-dihydroneopterin in some samples
was close to 1. Abnormally low amounts of 7,8-dihydroneop-
term in samples may be explainable by degradation of the
compound during sample-handling procedures. The 6-sub-
stituted 7,8-dihydropterin derivatives decompose rapidly to
7,8-dihydroxanthopterin if not properly protected from light
and air (13). However, samples for measurement of total
neopterins were handled with the necessary caution. In
contrast, neopterin is much more stable if kept protected
from light (14). Particularly high concentrations of total
neopteruns in some samples further argue for variations in
the concentrations of neopterin derivatives towards rein-
tively lower and higher 7,8-dihydroneopterin content.
Table 1. Concentrations of Neopterin, Total Neopterins, and 7,8-Dihydroneopterin In Urine of Homosexuals with
and without HiV-1 Antibody
MedIan,and 25-75 percentU. range, pmol per molecreatlnlne
Neopterin8
Totalneopterinsafteroxidation8
7,8-Dihydroneopterin (total neoptenns minus neoptenn)8
P <0.0001 Kruskal-Waliis test for differencesbetween groups.
HIV-1seronegative
(n = 73)
112, 91-144
418,326-486
298, 224-368
HIV-1seroposItlve
without AIDS (n = 69)
248, 194-416
958, 793-1559
713, 558-1152
HIV-1seroposltlve
with *ios (n = 8)
940, 572-1324
2869, 2162-4416
2009, 1493-3110
(n.s.)
CD4/CD8 -0.507
(<0.0001)
-0.405
(0.0005)
-0.001
(n.s.)
-0.525
(<0.0001)
0.014
-0.025
-0.076
-0.370
(0.001 6)
-0.023
(n.s.)
-0.479
(<0.0001)
0.008
-0.039
-0.075
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Table 2. CorrelatIon between Neopterin Variables and
T-Ceii Subpopulatlons in HIV-1-Seroposltive (n = 77)
and -Negative (n = 73) Homosexual Men
Re(Spearman rank correlation coeffIcIent)
T-cells Neopterln Total neopterins 7,8-Dlhydroneopterln
H!V-1-seropositive subjects
CD4 -0445
(0.0001)8
CD8 -0.023
H! V-1-seronegative subjecfs’
CD4 -0.026
CD8 -0.056
CD4/CD8 -0.078
8 P-valuesgiven in parentheses;n.s., not significant. bAll comparisonsnot
significantlydifferent.
All neopterin variables (i.e., neopterin, total neopterins,
and 7,8-dihydroneopterin) discriminated well between
HIV-l serological status in these subjects. The H1V-l-
seropositive men showed a close inverse correlation be-
tween neopterin concentrations and CD4 T-cell numbers
and CD4/CD8’ T-cell ratios (Table 2). This relationship
did not exist in the H1V-l-seronegative men, confirming
earlier results (7).
Our present results extend this observation to 7,8-dihy-
droneopterin. Concentrations of total neopterins and 7,8-
dihydroneopterin were also found to inversely correlate
with CD4 T-cell numbers and CD4/CD8 T-cell ratios in
the H1V-l-seropositive men. Elsewhere we have recently
shown that neopterin (8,15) and total neopterins (8) are of
similar value in predicting the onset of AIDS in H1V-
seropositive homosexual men.
Neopterin is produced and secreted by human macro-
phages on stimulation with y-interferon (5). Recently, in-
creased circulating y-interferon was found to parallel the
course of HIV-l infection, with AIDS patients having high-
est concentrations of y-interferon in serum (16). We as-
sumed that increased concentrations of 7,8-dihydroneop-
tern also reflect macrophage activity, in line with the
observation that macrophages stimulated by y-interferon
produce neopterin and 7,8-dthydroneopterin in parallel
(unpublished data). However, the concentrations of 7,8-
dihydroneopterin in vitro may be underestimated because
it will be partly destroyed during the culture period of three
days. Therefore, unless care is taken to ensure recovery of
dihydroneopterin, neopterin measurements may be more
reliable estimates of total neopterins in in-vitro systems.
Our data indicate that concentrations of neopterin and
total neopterins are of almost equal potential for clinical
diagnosis. Statistical evaluation in HIV-l-seropositive in-
dividuals demonstrates a close correlation between concen-
trations of neopterin and total neopterins in urine. We
speculate that the same associations can be found in other
conditions associated with activation of cellular immunity.
The same relation between neopterin and total neopterins
can be expected in serum samples. One may prefer to use
urine instead of serum samples because it is less infectious
and collection of samples is more convenient for patients
when they are not bled for other reasons. The diagnostic
quality of neopterin appears to be independent from the
choice of serum or urine as sample. However, measurement
of total neopterins by oxidation of 7,8-dihydroneopterin to
neopterin necessitates more strictly controlled sample col-
lection and handling to avoid degradation of the 7,8-
dihydro derivative. In addition, this sample preparation is
more time consuming and laborious than that for direct
quantification of neopterin. For quantification of naturally
occurring neopterin, samples are stable at room tempera-
ture for three days (17), which means that samples can be
mailed to specialized diagnostic laboratories.
This work was financially supported by the Austrian Research
Funds “Zur Forderung der Wissenschaftlichen Forschung,” p
6922M.
References
1. Danks DM. Pteridines and phenylketonurias. J Inherited
Metab Dis 1978;1:47-8.
2. Kaufman S. The structure of phenylalanine hydroxylation
cofactor. Proc NatI Aced Sci USA 1963;50:1085-93.
3. Kaufman S. The metabolic role of tetrahydrobiopterin. In:
Cooper BA, Whitehead VM, eds. Chemistry and biology of pte-
ridines. Berlin-New York: Walter de Gruyter, 1986:185-200.
4. Wachter H, Fuchs D, Hausen A, Reibnegger G, Werner ER.
Neopterin as marker for activation of cellular immunity: immu-
nological basis and clinical application [Review]. Adv Clin Chem
1989;27:81-141.
5. Fuchs D, Hausen A, Reibnegger G, Werner ER, Dierich MP,
Wachter H. Neopterin as a marker for activated cell-mediated
immunity: application in HIV-infection [Review). Immunol Today
1988;9:150-5.
6. Wachter H, Fuchs D, Hausen A, et al. Elevated urinary neop-
term levels in patients with the acquired immunodeficiency syn-
drome (AIDS). Hoppe Seylers Z Physiol Chem 1983;364:1345-6.
7. Fuchs D, Banekovich M, Hausen A, et al. Neopterin estimation
compared with the ratio of T-cell subpopulations in persons in-
fected with human immunodeficiency virus 1. Clin Chem
1988;34:2415-7.
8. Kramer A, Viktor SZ, Fuchs D, et al. Neopterin: a predictive
marker of acquired immunodeficiency syndrome in human immu-
nodeficiency virus infection. J AIDS 1989;2:291-6.
9. Werner ER, Bichler A, Daxenbichier 0, et al. Determination of
neopt.erin in serum and urine. Clin Chem 1987;33:62-6.
10. Abita JP, Cost H, Milstien S, Kaufman 5, Saimot 0. Urinary
neopterin and biopterin levels in patients with AIDS and AIDS-
related complex [Letter]. Lancet 1985;ii:51.
11. Goedert JJ, Biggar RI, Melbye M, et al. Effect of T4 count and
cofactors on AIDS incidence in homosexual men infected with
human immunodeficiency virus. J Am Med Assoc 1987;257:331-3.
12. Levine RA, Milstien S. The ratio of reduced to oxidized
neopterin and biopterin in human fluids: significance to the study
of human disease. In: Wachter H, Curtius HC, Pfleiderer W, eda.
Biochemical and clinical aspects of pteridines. Berlin-New York:
Walter de Gruyter, 1984:277-84.
13 Rembold H, Metzger H, Gutensohn W. Catabolism of pteridine
cofactors. Biochim Biophys Acts 1971;230:117-26.
14. Werner ER, Fuchs D, Hansen A, Reibnegger G, Wachter H.
Simultaneous determination of neopterin and creatinine in serum
with solid-phase extraction and on-line elution liquid chromatog-
raphy. Clin Chem 1988;34:466-.7.
15. Fuchs D, Spira TJ, Hausen A, et al. Neopterin as predictive
marker for disease progression in human immunodeficiency virus
type 1 infection. Clin Chem 1989;35:1746-9.
16. Fuchs D, Hausen A, Reibnegger G, et al. Interferon-gamma
concentrations are increased in sera from individuals infected with
human immunodeficiency virus type 1. J AIDS 1989;2:158-62.
17. Fuchs D, Hausen A, Reibnegger G, Wachter H. Automatized
routine estimation of neoptenn in human urine by HPLC on
reversed phase. Op. cit. (ref. 12): Vol. 1, 1982;67-79.
